Results 181 to 190 of about 8,310 (206)

Prevalence of Free Flap Failure in Patients Undergoing Reconstruction for Medication-Related Osteonecrosis of the Jaw: A Systematic Review and Meta-Analysis. [PDF]

Clin Pract
Kostares E, Kostare G, Kostares M, Pitsigavdaki F, Kyrgidis A, Perisanidis C, Kantzanou M.   +6 more
europepmc   +1 more source

Medication-related osteonecrosis of the jaw primary prevention: multidomain long-term intervention versus pre-bisphosphonate treatment standalone dental intervention. A retrospective multi-center comparative cohort study. [PDF]

Support Care Cancer
Mauceri R, La Mantia G, Di Fede O, Fusco V, Marcianò A, Coppini M, Seminara G, Panzarella V, Coniglio R, Pizzo G, Tozzo P, Matranga D, Maniscalco L, Oteri G, Campisi G.   +14 more
europepmc   +1 more source

Letter to the Editor : Novel evidence on bisphosphonate related osteochemonecrosis of the jaws suggests tooth extractions and overdentures as risk factors [PDF]

, 2009
Kyrgidis, Athanassios, Vahtsevanos, Konstantinos   +1 more
core  

Analysis of prosthetic risk factors for peri-implant medication-related osteonecrosis of the jaw: an observational study. [PDF]

Sci Rep
Kim DY, Choi S, Han JJ.
europepmc   +1 more source

Denosumab Dosage and Tooth Extraction Predict Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer and Bone Metastases. [PDF]

Cancers (Basel)
Yokoo S, Kubo S, Yamamoto D, Ikeda M, Yamashita T, Yoshikawa K, Mese H, Ohara S.   +7 more
europepmc   +1 more source

Osteoporosis Management after the Occurrence of Medication-Related Osteonecrosis of the Jaw: A 13-Year Experience at a Tertiary Center. [PDF]

Endocrinol Metab (Seoul)
Wong CH, Tsoi KH, Pu JJ, Jiang NS, Chan SSY, Loong CHN, Zou X, Fong CHY, Leung EKH, Lee ACH, Lee CH, Tan KCB, Woo YC, Su YX, Lui DTW.   +14 more
europepmc   +1 more source

Pharmacological Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) with Pentoxifylline and Tocopherol. [PDF]

J Clin Med
Słowik Ł, Totoń E, Nowak A, Wysocka-Słowik A, Okła M, Ślebioda Z.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Medication-related osteonecrosis of the jaw

InnovAiT: Education and inspiration for general practice, 2020
Medication-related osteonecrosis of the jaw (MRONJ) is a rare, but well-documented, complication following the administration of anti-resorptive and anti-angiogenic drugs. MRONJ has a negative effect on quality of life, and can result in reduced social contact, pain and masticatory difficulties.
Kishan Patel, Emma Walshaw, Charolene Aranha   +2 more
openaire   +2 more sources

Preventing medication-related osteonecrosis of the jaw

BMJ, 2019
### What you need to know Osteonecrosis of the jaw is a severe adverse effect reported with certain drugs commonly used in the treatment of cancers and osteoporosis. Although rare, it can severely impair quality of life.1 The number and type of drugs associated with osteonecrosis of the jaw continue to increase, as do their indications.
Lara, Zebic, Vinod, Patel
openaire   +2 more sources